These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33360502)

  • 1. Analysis of lutetium-177 production at the WWR-K research reactor.
    Sairanbayev D; Koltochnik S; Shaimerdenov A; Chakrova Y; Gurin A; Kenzhin Y
    Appl Radiat Isot; 2021 Mar; 169():109561. PubMed ID: 33360502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale production of lutetium-177m for the
    Bhardwaj R; Ponsard B; Sarilar M; Wolterbeek B; Denkova A; Serra-Crespo P
    Appl Radiat Isot; 2020 Feb; 156():108986. PubMed ID: 31786419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of No-Carrier Added Lutetium-177 by Irradiation of Enriched Ytterbium-176.
    Tarasov VA; Andreev OI; Romanov EG; Kuznetsov RA; Kupriyanov VV; Tselishchev IV
    Curr Radiopharm; 2015; 8(2):95-106. PubMed ID: 25771378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiation capsule design for neutron coloration of topaz in a WWR-K reactor.
    Akhanov AM; Aitkulov MT; Sairanbayev DS; Gizatulin SK; Romanova NK; Shaimerdenov AA; Chikhray YV; Ualzhanov Z; Zholdybayev TK
    Appl Radiat Isot; 2022 Dec; 190():110472. PubMed ID: 36170762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feasibility study of
    Golabian A; Hosseini MA; Ahmadi M; Soleimani B; Rezvanifard M
    Appl Radiat Isot; 2018 Jan; 131():62-66. PubMed ID: 29173809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide generator-based production of therapeutic 
    Bhardwaj R; Wolterbeek HT; Denkova AG; Serra-Crespo P
    EJNMMI Radiopharm Chem; 2019 Jul; 4(1):13. PubMed ID: 31659496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
    Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
    Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical optimization of production by deuteron irradiation of high specific activity (177g)Lu suitable for radioimmunotherapy.
    Manenti S; Bonardi ML; Gini L; Groppi F
    Nucl Med Biol; 2014; 41(5):407-9. PubMed ID: 24666720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum averaged cross section measurements of lutetium using standard
    Schulc M; Košťál M; Czakoj T; Novák E; Šimon J; Hynková N; Capote R
    Appl Radiat Isot; 2022 Oct; 188():110378. PubMed ID: 35841849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect Production of No Carrier Added (NCA) (177)Lu from Irradiation of Enriched (176)Yb: Options for Ytterbium/Lutetium Separation.
    Dash A; Chakravarty R; Knapp FF; Pillai AM
    Curr Radiopharm; 2015; 8(2):107-18. PubMed ID: 25771377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the yield of (177)Lu radionuclide produced by the cyclic irradiation technique.
    Odame Duodu G; Akaho EH; Serfor-Armah Y; Nyarko BJ; Afi Achoribo E
    Appl Radiat Isot; 2011 Mar; 69(3):588-93. PubMed ID: 21177113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production, quality control, biodistribution assessment and preliminary dose evaluation of (177)Lu-PDTMP as a possible bone palliative agent.
    Yousefnia H; Jalilian AR; Zolghadri S; Ghannadi-Maragheh M
    Nucl Med Commun; 2014 Jan; 35(1):99-107. PubMed ID: 24162837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu(n,gamma)177Lu.
    Dvorakova Z; Henkelmann R; Lin X; Türler A; Gerstenberg H
    Appl Radiat Isot; 2008 Feb; 66(2):147-51. PubMed ID: 17900914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed design for the PGAA facility at the TRIGA IPR-R1 research reactor.
    Guerra BT; Jacimovic R; Menezes MA; Leal AS
    Springerplus; 2013; 2():597. PubMed ID: 24294545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the
    Balzer M; Spiecker F; Bluemel S; Amthauer H; Brenner W; Spreckelmeyer S
    EJNMMI Radiopharm Chem; 2023 Nov; 8(1):37. PubMed ID: 37930495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of [
    Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
    Nucl Med Biol; 2019; 78-79():31-40. PubMed ID: 31731177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational analysis of the dose rates at JSI TRIGA reactor irradiation facilities.
    Ambrožič K; Žerovnik G; Snoj L
    Appl Radiat Isot; 2017 Dec; 130():140-152. PubMed ID: 28965017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of advances in the last decade on targeted cancer therapy using
    Chakravarty R; Chakraborty S
    Am J Nucl Med Mol Imaging; 2021; 11(6):443-475. PubMed ID: 35003885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling of the
    Bhardwaj R; Wolterbeek HT; Denkova AG; Serra-Crespo P
    Appl Radiat Isot; 2020 Dec; 166():109261. PubMed ID: 32961525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bulk Scale Formulation of Therapeutic Doses of Clinical Grade Ready-to-Use
    Mathur A; Prashant V; Sakhare N; Chakraborty S; Vimalnath KV; Mohan RK; Arjun C; Karkhanis B; Seshan R; Basu S; Korde A; Banerjee S; Dash A; Sachdev SS
    Cancer Biother Radiopharm; 2017 Sep; 32(7):266-273. PubMed ID: 28910148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.